Up-to-date news about Intravacc
Stay informed about the latest developments in our mission to pioneer transformative vaccines with up-to-date corporate communications. Get the latest news on our development and business milestones, as well as industry insights, partnership announcements, and corporate reports.
![](/fileadmin/_processed_/9/7/csm_paul-news_f03d62b06d.jpg)
We interviewed Paul, our new Director QA/QC & EHS to learn about his career and his passion for quality.
![](/fileadmin/_processed_/7/c/csm_First-Dutch-Innovations-FDI__c6556d1e58.png)
On the third of May last year the Ministry of Health, Welfare, and Sport (VWS) announced the sale of Intravacc B.V. and on December 28, 2023 VWS…
![Annual Report 2022 Annual Report 2022](/fileadmin/_processed_/5/2/csm_Annual-Report-2022_5bbb98ff66.jpg)
Intravacc publishes 2022 annual report
![](/fileadmin/_processed_/9/c/csm_Boston-2023-01_4e2c25d5a5.jpg)
Looking back on a successful Bio International 2023 in Boston!
![](/fileadmin/_processed_/6/9/csm_corporate-4_617bcb2964.jpg)
Meet the new Business Development Team
![](/fileadmin/_processed_/0/b/csm_corporate-11_1415487483.jpg)
Dutch State Announces the Sale of Intravacc B.V. (The Netherlands)
![Annual Report 2021 Annual Report 2021](/fileadmin/_processed_/d/0/csm_Annual-Report-2021_39c5905fb4.jpg)
Intravacc publishes 2021 Annual Report and announces expansion of its management team and board of directors
![](/fileadmin/_processed_/4/1/csm_corporate-5_330417d8ce.jpg)
Intravacc announces positive pre-clinical data for its OMV-based Lyme vaccine
![](/fileadmin/01-Website/02-News/2023/Corporate/natalie-news.jpg)
Intravacc Announces Appointment of Nathalie Laarakker as Chief Financial Officer
![corporate 7 corporate 7](/fileadmin/01-Website/02-News/2023/Corporate/corporate-7.jpg)
Intravacc appoints three Supervisory Board members